G9218 HCPCS PCP Prophylaxis Reimbursement

HCPCS Level II code G9218 documents that PCP (Pneumocystis pneumonia) prophylaxis was not prescribed within three months after documentation of a CD4+ cell count below 500 cells/mm3 or a CD4 percentage below 15%, and that no reason was provided. As a quality-reporting and care-continuity marker, this code highlights missed preventive therapy opportunities for immunocompromised patients, with implications for patient safety and population health management nationally. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise explanation of the code's clinical context and service setting, plus what to expect from payer coverage patterns and benchmarking materials where available. The publication covers common use cases for G9218, how it functions in quality measurement and claims documentation, relevant policy considerations affecting national reporting, and the clinical rationale behind documenting prophylaxis omissions. When specific data elements were not provided in the source, the text clearly notes that the information is not available in the input. The content is intended to inform coding professionals, payers, and health system administrators about the purpose of G9218 and its role in tracking gaps in PCP prophylaxis among patients with low CD4 counts.

Billing Code Overview

HCPCS Level II code G9218 indicates that PCP (Pneumocystis pneumonia) prophylaxis was not prescribed within 3 months of a low CD4+ cell count below 500 cells/mm3 or a CD4 percentage below 15%, and that no reason was given for the omission. This code documents a preventive medication gap for patients with immune suppression documented by CD4 criteria.

Service Type: Preventive/quality reporting — HIV-related prophylaxis omission

Typical Site of Service: Outpatient infectious disease or primary care clinic

Data not available in the input.

Clinical Context

A 38-year-old patient with known HIV infection presents for routine follow-up after recent laboratory results show a CD4+ T-lymphocyte count of 420 cells/mm3 and a CD4 percentage of 12%. The patient’s medical record does not document prescription of PCP (Pneumocystis jirovecii pneumonia) prophylaxis within the prior three months. The HIV care clinician reviews the chart, documents the low CD4 parameters, counsels the patient on infection risk, and records the reason for not prescribing prophylaxis as not given. The clinical workflow includes review of recent labs, medication reconciliation, assessment for contraindications to trimethoprim-sulfamethoxazole (TMP-SMX) or alternative agents, documentation of decision-making in the electronic health record, and order entry if prophylaxis is initiated. If prophylaxis is not prescribed and no reason is recorded, the visit is coded with billing code G9218 to indicate that PCP prophylaxis was not prescribed within three months of a qualifying low CD4 count or percentage and no reason was documented.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service	Use when an E/M visit is performed on the same day as another service and is distinct from the prophylaxis documentation visit.

Taxonomy Code	Specialty	Notes
`207RH0000X`	Infectious Disease Specialist	Manages HIV care and decisions about PCP prophylaxis.
`208000000X`	Internal Medicine	Primary care providers who manage chronic HIV patients and preventive therapies.
`2084P0800X`	HIV/AIDS Specialist	Clinicians with focused practice in HIV care who commonly prescribe prophylaxis.
`363L00000X`	Nurse Practitioner (Primary Care)	NPs in outpatient clinics who perform medication reconciliation and counseling.
`207Q00000X`	Family Medicine	Family physicians providing longitudinal HIV care and preventive services.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`B20`	Human immunodeficiency virus [HIV] disease	Primary diagnosis for patients with HIV who require assessment for PCP prophylaxis based on CD4 counts.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	May prompt follow-up and reassessment of prophylaxis needs if HIV status is being confirmed.
`Z21`	Asymptomatic human immunodeficiency virus [HIV] infection status	Used for patients with HIV not currently symptomatic but with low CD4 counts triggering prophylaxis consideration.
`D70.9`	Neutropenia, unspecified	Hematologic conditions that may affect prophylaxis choices or contraindications to certain antimicrobials.
`T88.1XXA`	Allergy, unspecified, initial encounter	Documented drug allergies (e.g., sulfa allergy) influence selection or avoidance of TMP-SMX for PCP prophylaxis.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99406`	Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes	May be performed in the same visit if counseling on preventive measures and medication adherence is provided; often billed alongside E/M services when counseling is a distinct component.
`99407`	Smoking and tobacco use cessation counseling visit, intensive, greater than 10 minutes	As above, used when prolonged counseling is documented during the same encounter.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for the follow-up visit in which low CD4 results are reviewed and prophylaxis decision is documented.
`36415`	Collection of venous blood by venipuncture	Often performed prior to the visit or during the visit to obtain CD4 count and other labs that inform PCP prophylaxis decisions.
`81002`	Urinalysis, non-automated, without microscope	May be performed as part of baseline screening before initiating prophylactic antibiotics (e.g., for TMP-SMX considerations).

OpenPayer

Summary & Overview

HCPCS G9218: PCP Prophylaxis Not Prescribed After Low CD4